Total Funding
33
52
Total FundingGrant raised
Growth Score
-2 pts
Heat Score
-4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
186010
Spectra Plasmonics is a drug-checking technology which detect trace amounts of dangerous substances.
- Christian Baldwin: Co-Founder & Chief Operating Officer
Maarij Baig: Chief Scientific OfficerPast Role: Medella Health, Chief Scientific Officer
About the Company
Spectra Plasmonics provides portable technology that offers chemical sensing products. Their core technology is Amplifi ID, which enables chemical analysis without complex lab steps. It offers an optimal, high-performance drug checking solution. They provide software that generates a report for each scanned drug about the detected sample contents.
